<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="48487">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01768728</url>
  </required_header>
  <id_info>
    <org_study_id>SRRSH20121225-1</org_study_id>
    <nct_id>NCT01768728</nct_id>
  </id_info>
  <brief_title>Laparoscopic Versus Open Left Hemihepatectomy for Liver Benign Lesions</brief_title>
  <official_title>A Randomized Controlled Trial of Acute Surgical Trauma and Stress Response of Laparoscopic Versus Open Left Hemihepatectomy for Liver Benign Lesions</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sir Run Run Shaw Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sir Run Run Shaw Hospital</source>
  <oversight_info>
    <authority>China: Ministry of Health</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate the influence of the laparoscopic and open left
      hemihepatectomy on acute surgical trauma and stress response.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2012</start_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Plasma C-reactive protein (CRP) level</measure>
    <time_frame>up to 7 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>CRP will be tested before operation, 3,12,24 hours and 3,5,7 days after operation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Inflammatory response markers including interleukin-6, interleukin-10 concentrations and tumor necrosis factor Î± level in serum</measure>
    <time_frame>up to 7 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>interleukin-6 and interleukin-10 will be tested before operation, 3,12,24 hours and 3,5,7 days after operation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oxidative stress status including plasma malondialdehyde level and total antioxidant capacity</measure>
    <time_frame>up to 7 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>plasma malondialdehyde level and total antioxidant capacity will be tested before operation, 3,12,24 hours and 3,5,7 days after operation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Immune status including white blood cell count and human leukocyte antigen DR (HLA-DR) expression</measure>
    <time_frame>up to 7 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>white blood cell count and human leukocyte antigen DR (HLA-DR) expression will be tested before operation, 3,12,24 hours and 3,5,7 days after operation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Status of insulin resistant</measure>
    <time_frame>up to 7 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>Status of insulin resistant will be tested before operation, 3,12,24 hours and 3,5,7 days after operation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Systemic inflammatory response syndrome</measure>
    <time_frame>up to 7 days</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Status of hepatic cell apoptosis including hematoxylin and eosin (HE) staining, immunohistochemistry staining and caspase-3 expression</measure>
    <time_frame>24 hours</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to functional recovery</measure>
    <time_frame>Participants will be followed for the duration of hospital stay,  an expected average of 7 days</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative hospital stay</measure>
    <time_frame>Participants will be followed for the duration of hospital stay,  an expected average of 8 days</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Morbidity and mortality</measure>
    <time_frame>up to 1 month</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>up to 1 month</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intraoperative parameters including operation time, pneumoperitoneum time, liver resection time, intraoperative estimated blood loss,transfusion</measure>
    <time_frame>participants will be followed for the duration of operation, an expected average of 120 minutes</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <other_outcome>
    <measure>Hospital costs</measure>
    <time_frame>Participants will be followed for the duration of hospital stay, an expected average of 10 days</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Benign Lesions in Left Liver</condition>
  <arm_group>
    <arm_group_label>Laparoscopic left hemihepatectomy group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Group of patients that are operated with laparoscopic left hemihepatectomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Open left hemihepatectomy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Group of patients operated with open left hemihepatectomy</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Laparoscopic  left hemihepatectomy</intervention_name>
    <description>participants will be performed with laparoscopic left hepatectomy using laparoscopic instruments</description>
    <arm_group_label>Laparoscopic left hemihepatectomy group</arm_group_label>
    <other_name>Laparoscopic left hepatectomy</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Open  left hemihepatectomy</intervention_name>
    <description>participants will be performed with traditional open left hepatectomy using laparotomic instruments</description>
    <arm_group_label>Open left hemihepatectomy</arm_group_label>
    <other_name>Open left hepatectomy</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patient with benign lesions who requires left hemihepatectomy

          -  Child-Pugh classification of A to B

          -  American Society Of Anesthesiologists (ASA) grading of I to III

          -  a body mass index of between 18 and 35

          -  willingness to participate in the study

          -  able to understand the nature of the study and what will be required of them

        Exclusion Criteria:

          -  pregnant or lactating women

          -  unwillingness to participate

          -  Child-Pugh classification of C

          -  ASA grading of IV to V

          -  with condition of acute inflammatory,fever or diabetes mellitus

          -  with autoimmune disease or immunodeficiency

          -  taking drugs that affect the immune system
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Xiujun Cai, MD</last_name>
    <phone>0086-0571-86006605</phone>
    <email>caixiujunzju@yahoo.com.cn</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of General Surgery, Institute of Minimally Invasive Surgery, Sir Run Run Shaw Hospital</name>
      <address>
        <city>Hangzhou</city>
        <state>Zhejiang</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xiujun Cai, MD</last_name>
      <phone>0086-0571-86006605</phone>
      <email>caixiujunzju@yahoo.com.cn</email>
    </contact>
    <contact_backup>
      <last_name>Renan Jin, MS</last_name>
      <phone>0086-0571-86006276</phone>
      <email>jason198508@126.com</email>
    </contact_backup>
    <investigator>
      <last_name>Xiujun Cai, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>January 2013</verification_date>
  <lastchanged_date>January 14, 2013</lastchanged_date>
  <firstreceived_date>January 9, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sir Run Run Shaw Hospital</investigator_affiliation>
    <investigator_full_name>Xiujun Cai</investigator_full_name>
    <investigator_title>Executive Vice-President</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
